Michael Oberle completed an Engineering Diploma in Electrical Engineering at the Technical University of Karlsruhe, Germany, in 1993, and a PhD degree in Microelectronics at the Swiss Federal Institute of Technology (ETH) Zurich in 2002.
Michael was co-founder and CEO of Miromico AG (2001 – 2005), a start-up company spun off from the Integrated Systems Laboratory of the ETH Zurich, doing business in R&D of miniaturized medical devices and contract application-specific integrated circuit (ASIC) design. In 2005, he joined SPEAG and IT'IS to establish and develop the new medical technology division, and, in 2007, he became Managing Director of the newly founded Zurich MedTech AG. Before returning to Z43 in 2016 to lead business development at ZMT, Michael served as CEO of NeMoDevice AG (2012 – 2016), a Zurich-based medical device company that provides innovative solutions for monitoring cerebral blood flow and brain tissue oxygenation in the field of neurointensive medicine.
Michael was named CEO of ZMT in November 2016.